In our results, inhibition of CDCA2 sensitized Huh7 cells and enhanced the sensitivity of SK-Hep1 and HepG2 cells to CDDP-induced apoptosis, suggesting a potential therapeutic value of targeting CDCA2 in reducing the chemoresistance of HCC to cisplatin. The gene discussed is CDCA2; the disease is hepatocellular carcinoma.